{
    "2019-02-05": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Novo Nordisk Is on the Upswing -- for Now",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Upswing"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Sanofi's Myeloma Candidate Meets Goal in Phase III Study",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Myeloma",
                        "Phase III",
                        "Goal"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Merck's Keytruda Clinches CHMP Nod for Difficult Lung Cancer",
                "features": {
                    "keywords": [
                        "Merck",
                        "Keytruda",
                        "CHMP",
                        "Lung Cancer"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}